Stephanie Ann Sweetana

Title: The Innovative Contributions of Stephanie Ann Sweetana

Introduction

Stephanie Ann Sweetana is a prominent inventor based in Bloomington, IN (US). She has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. Her work focuses on developing innovative formulations that enhance the stability and efficacy of pharmaceutical compounds.

Latest Patents

Among her latest patents is the invention of echinocandin pharmaceutical formulations containing micelle-forming surfactants. This patent describes formulations that comprise an echinocandin compound or echinocandin/carbohydrate complex combined with a pharmaceutically acceptable micelle-forming surfactant in a non-toxic aqueous solvent. The goal is to optimize the solubilization of the echinocandin compound while maintaining the ability to freeze-dry the solution, resulting in increased stability for both the solution and freeze-dried formulations. Additionally, she has developed prodrugs of excitatory amino acids, which relate to synthetic excitatory amino acid prodrugs and their preparation processes. This invention also includes methods of using these compounds for treating neurological and psychiatric disorders.

Career Highlights

Stephanie has worked with notable companies, including Eli Lilly and Company, where she has contributed her expertise in pharmaceutical innovations. Her career reflects a commitment to advancing medical science through her inventive work.

Collaborations

Throughout her career, Stephanie has collaborated with esteemed colleagues such as Arvind L Thakkar and Lowell L Gibson. These partnerships have further enriched her contributions to the field.

Conclusion

Stephanie Ann Sweetana's innovative work in pharmaceutical formulations showcases her dedication to improving drug stability and efficacy. Her patents reflect a significant impact on the treatment of various medical conditions, highlighting her role as a leading inventor in the pharmaceutical industry.